|
51
|
Miller JF, Chong PY, Shotwell JB, Catalano JG, Tai VWF, Fang J, Banka AL, Roberts CD, Youngman M, Zhang H, Xiong Z, Mathis A, Pouliot JJ, Hamatake RK, Price DJ, Seal JW, Stroup LL, Creech KL, Carballo LH, Todd D, Spaltenstein A, Furst S, Hong Z, Peat AJ. Hepatitis C Replication Inhibitors That Target the Viral NS4B Protein. J Med Chem 2013; 57:2107-20. [DOI: 10.1021/jm400125h] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- John F. Miller
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Pek Y. Chong
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - J. Brad Shotwell
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - John G. Catalano
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Vincent W.-F. Tai
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Jing Fang
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Anna L. Banka
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Christopher D. Roberts
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Michael Youngman
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Huichang Zhang
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Zhiping Xiong
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Amanda Mathis
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Jeffery J. Pouliot
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Robert K. Hamatake
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Daniel J. Price
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - John W. Seal
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Lisa L. Stroup
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Katrina L. Creech
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Luz H. Carballo
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Dan Todd
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Andrew Spaltenstein
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Sylvia Furst
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Zhi Hong
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| | - Andrew J. Peat
- GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park,
North Carolina 27709, United States
| |
Collapse
|
|
52
|
Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res 2012; 96:115-26. [PMID: 22995600 DOI: 10.1016/j.antiviral.2012.09.007] [Citation(s) in RCA: 81] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2012] [Revised: 09/03/2012] [Accepted: 09/07/2012] [Indexed: 02/07/2023]
Abstract
Development of anti-dengue therapy represents an urgent un-met medical need. Towards antiviral therapy, recent advances in crystal structures of DENV enzymes have led to the possibility of structure-based rational design of inhibitors for anti-dengue therapy. These include (i) the structure of the 'active' form of the DENV protease in complex with a peptide substrate; (ii) the structure of DENV methyltransferase bound to an inhibitor that selectively suppresses viral methyltransferase, but not human methyltransferases; (iii) the structure of DENV RNA-dependent RNA polymerase in complex with a small-molecule compound. This review summarizes the structural biology of these three key enzymes (protease, methyltransferase, and polymerase) that are essential for DENV replication. The new structural information has provided new avenues for development of anti-dengue therapy.
Collapse
|